A Hiroshima-University-led research team has discovered a key gene responsible for the initiation of gemma development, ...
Caris Life Sciences ® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine ...
When someone is infected with Ebola, the body mounts a strong immune response, as it does in response to many pathogens.
Multivariate analyses reveal that pathologic complete response is associated with transcriptomic differences and chemotherapy type, rather than self-reported race Agendia, Inc., a leader in precision ...
Next-generation sequencing (NGS) is transforming research by delivering rapid, high-quality genetic data through streamlined workflows, automation, and advanced logistics. Eurofins Genomics combines ...
Download this application note to learn more about targeted sequencing approaches such as RNA exome sequencing. Is the form ...
Researchers explored the cellular cross-talk between endothelial cells and macrophages contributing to peripheral vascular ...
Life science company 10x Genomics has launched Atera, a biology platform designed to deliver whole-transcriptome spatial ...
New research shows how certain orphan noncoding RNA — oncRNA — can be predictable enough to be a ‘bar code’ identifying ...
A robust and quantitative map links chromatin modification and gene expression of cells during zebrafish embryogenesis.
IRVING, Texas, April 20, 2026 /PRNewswire/ -- Caris Life Sciences (R) (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today announced it ...
(spidroins) through long-read transcriptomics across a broad phylogenetic range, with theoretical implications for protein family evolution, biomaterials, and silk biology. By identifying putative ...